Search results
AHN Honors Neurosciences
Erie News Now Plus· 1 day agoThe event featured music, dinner and charity auctions, with the money raised benefiting neurosciences at the hospital.
Alto Neuroscience schizophrenia treatment shows good phase 1 results
Seeking Alpha· 5 days agoALTO-101, a PDE4 inhibitor by Alto Neuroscience, shows promising results in phase 1 trial for...
▶️ Listen Now: The benefits of teaching kids about neuroscience
WBEZ 91.5 Chicago· 5 days agoWhen people are science literate, they could be more health literate too.
To be better at neuroscience, Biogen will invest outside the therapeutic area
FierceBiotech· 4 days agoTo be a better neuroscience company, Biogen is going to have to diversify—outside of the therapeutic...
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In...
Benzinga via Yahoo Finance· 5 days agoRecently listed Alto Neuroscience Inc (NYSE:ANRO) released results from its healthy volunteer Phase...
Alto Neuroscience reports positive Phase 1 results for ALTO-101 By Investing.com
Investing.com· 5 days agoAlto Neuroscience, Inc. (NYSE: ANRO) announced today that its Phase 1 study of ALTO-101, a novel...
...Renowned Neurosurgeon Dr. Adam Kanter as Executive Medical Director of its Nationally Ranked...
WKBN 27 Youngstown· 6 days agoHoag announced today Adam Kanter, M.D., F.A.A.N.S, has been named Executive Medical Director of the Pickup Family Neurosciences Institute. Dr. Kanter will lead a multidisciplinary ...
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical...
Morningstar· 4 days ago...Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke...
New Haven and neuroscience: Match made in heaven?
Hartford Business Journal· 2 days agoThe announcement last spring by Yale New Haven Health of plans to develop an $838 million neurosciences facility on its St. Raphael campus marked New...
Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
SciTechDaily· 1 day agoResearchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic...